AI Article Synopsis

  • The study investigates how platelet levels and the platelet to mean platelet volume (PLT/MPV) ratio affect the prognosis of advanced esophageal squamous cell carcinoma (ESCC) patients treated with apatinib.
  • Retrospective analysis of 80 advanced ESCC patients showed that higher PLT and PLT/MPV ratios correlated with better progression-free survival (PFS), with significant findings (156 days vs. 80 days and 157 days vs. 85 days, respectively).
  • Multivariate analysis indicated that a high pretreatment PLT/MPV ratio was an independent predictor of longer PFS, suggesting that these blood parameters may help assess treatment outcomes in patients receiving later lines of apatinib therapy

Article Abstract

Apatinib has a certain efficacy for advanced esophageal squamous cell carcinoma (ESCC). This study aimed to investigate the prognostic significance of platelet (PLT) and platelet to mean platelet volume (PLT/MPV) ratio for advanced ESCC patients with apatinib second-line or late-line treatment. A retrospective study included 80 patients with advanced ESCC who received Apatinib ≥ 2 lines targeted therapy. We collected baseline clinical characteristics and blood parameters from the patients. Kaplan-Meier plots and univariate and multivariate analysis were used to find the factors related to progression-free survival (PFS). The optimal cut-off values of PLT and PLT/MPV ratio were determined by X-tile software. Kaplan-Meier analysis demonstrated that patients in the high PLT group had better PFS than those in the low PLT group (156 d vs 80 d, <.001), and patients in the high PLT/MPV ratio group had better PFS than those in low PLT/MPV ratio group (157 d vs 85 d, <.001). Univariate analysis revealed pretreatment PLT and PLT/MPV ratio were significantly correlated with PFS. Multivariate analysis revealed high levels of pretreatment PLT/MPV ratio was an independent predictor of longer PFS (HR: 0.257, 95% CI: 0.089-0.743,  = .012). High levels of baseline PLT and PLT/MPV may indicate a better prognosis in apatinib ≥ 2 lines treatment for advanced ESCC patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808027PMC
http://dx.doi.org/10.1177/15330338211072974DOI Listing

Publication Analysis

Top Keywords

plt/mpv ratio
12
prognostic significance
8
significance platelet
8
platelet plt
8
plt platelet
8
platelet platelet
8
platelet volume
8
volume plt/mpv
8
apatinib second-line
8
second-line late-line
8

Similar Publications

Objective: This prospective case-control study examined the novel immunoinflammatory markers obtained from blood counts of patients with Graves' orbitopathy (GO), Graves' disease (GD) and healthy subjects.

Methods: Demographic data, white cell count parameters, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), platelet-to-neutrophil ratio (PNR), red cell distribution width (RDW), RDW-to-platelet ratio (RDW/PLT), MPV-to-lymphocyte ratio (MPV/ALC), eosinophil-to-lymphocyte ratio (ELR) and systemic immune-inflammatory index (SII) were evaluated. The European Group on Graves Orbitopathy scale and Clinical Activity Score were used for clinical activity and severity assessment.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared coagulation and platelet parameters between 202 women with spontaneous premature ovarian insufficiency (POI) and 202 age-matched controls with benign gynecological conditions.
  • Results showed women with POI had higher fibrinogen levels and platelet distribution width (PDW), but lower platelet count, mean platelet volume, and plateletcrit levels, indicating potential abnormalities in platelet function.
  • The findings suggest that women with POI may have increased cardiovascular disease risk due to altered platelet and fibrinogen levels, but no significant coagulation abnormalities were found.
View Article and Find Full Text PDF

Platelet and Lymphocyte-Related Parameters as Potential Markers of Osteoarthritis Severity: A Cross-Sectional Study.

Biomedicines

September 2024

Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy.

Background: Platelets and lymphocytes levels are important in assessing systemic disorders, reflecting inflammatory and immune responses. This study investigated the relationship between blood parameters (platelet count (PLT), mean platelet volume (MPV), lymphocyte count (LINF), and platelet-to-lymphocyte ratio (PLR)) and osteoarthritis (OA) severity, considering age, sex, and body mass index (BMI).

Methods: Patients aged ≥40 years were included in this cross-sectional study and divided into groups based on knee OA severity using the Kellgren-Lawrence (KL) grading system.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify factors influencing gastrointestinal bleeding in children with abdominal-type Henoch-Schonlein purpura (HSP) and evaluate the diagnostic usefulness of the platelet-to-lymphocyte ratio (PLR).
  • Researchers analyzed medical records from 112 children with abdominal HSP, categorizing them into bleeding and non-bleeding groups, while comparing PLR and other blood indicators between the two.
  • Results showed that higher PLR and white blood cell counts were significant risk factors for gastrointestinal bleeding, and PLR also had strong predictive value for both bleeding risk and treatment efficacy.
View Article and Find Full Text PDF

Objectives: Chronic obstructive pulmonary disease (COPD) is a complex inflammatory condition that primarily impairs respiration but can also affect hemostasis. This study aimed to determine differences in platelet-related parameters and eosinophil between COPD patients and healthy controls.

Methods: We included 149 patients with stable COPD and 30 healthy controls who were recruited from the outpatient department of Chest Diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!